These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8427878)

  • 1. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin.
    Kamata Y; Kimura Y; Hiroi T; Sakaguchi G; Kozaki S
    Biochim Biophys Acta; 1993 Feb; 1156(2):213-8. PubMed ID: 8427878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC; Hambleton P; Melling J
    Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of a protease-sensitive acceptor component in mouse brain synaptosomes for Clostridium botulinum type B neurotoxin.
    Ogasawara J; Kamata Y; Sakaguchi G; Kozaki S
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):351-5. PubMed ID: 2060767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between Clostridium botulinum neurotoxin and gangliosides.
    Kitamura M; Iwamori M; Nagai Y
    Biochim Biophys Acta; 1980 Mar; 628(3):328-35. PubMed ID: 6768400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
    Rummel A; Mahrhold S; Bigalke H; Binz T
    Mol Microbiol; 2004 Feb; 51(3):631-43. PubMed ID: 14731268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids.
    Kamata Y; Kozaki S; Sakaguchi G; Iwamori M; Nagai Y
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1015-9. PubMed ID: 3778479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.
    Kozaki S; Miki A; Kamata Y; Ogasawara J; Sakaguchi G
    Infect Immun; 1989 Sep; 57(9):2634-9. PubMed ID: 2668181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins.
    Tsukamoto K; Kohda T; Mukamoto M; Takeuchi K; Ihara H; Saito M; Kozaki S
    J Biol Chem; 2005 Oct; 280(42):35164-71. PubMed ID: 16115873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLC immunostaining characterization of Clostridium botulinum type A neurotoxin binding to gangliosides and free fatty acids.
    Takamizawa K; Iwamori M; Kozaki S; Sakaguchi G; Tanaka R; Takayama H; Nagai Y
    FEBS Lett; 1986 Jun; 201(2):229-32. PubMed ID: 3709810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes.
    Wadsworth JD; Desai M; Tranter HS; King HJ; Hambleton P; Melling J; Dolly JO; Shone CC
    Biochem J; 1990 May; 268(1):123-8. PubMed ID: 2188647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a.
    Nishiki T; Tokuyama Y; Kamata Y; Nemoto Y; Yoshida A; Sato K; Sekiguchi M; Takahashi M; Kozaki S
    FEBS Lett; 1996 Jan; 378(3):253-7. PubMed ID: 8557112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex.
    Kohda T; Ihara H; Seto Y; Tsutsuki H; Mukamoto M; Kozaki S
    Microb Pathog; 2007; 42(2-3):72-9. PubMed ID: 17188834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain.
    Zhou Y; Singh BR
    Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes.
    Nishiki T; Kamata Y; Nemoto Y; Omori A; Ito T; Takahashi M; Kozaki S
    J Biol Chem; 1994 Apr; 269(14):10498-503. PubMed ID: 8144634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D.
    Tsukamoto K; Kozai Y; Ihara H; Kohda T; Mukamoto M; Tsuji T; Kozaki S
    Microb Pathog; 2008 Jun; 44(6):484-93. PubMed ID: 18242046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner.
    Strotmeier J; Lee K; Völker AK; Mahrhold S; Zong Y; Zeiser J; Zhou J; Pich A; Bigalke H; Binz T; Rummel A; Jin R
    Biochem J; 2010 Oct; 431(2):207-16. PubMed ID: 20704566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
    Atassi MZ; Taruishi M; Naqvi M; Steward LE; Aoki KR
    Protein J; 2014 Jun; 33(3):278-88. PubMed ID: 24740609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.
    Kozaki S; Ogasawara J; Shimote Y; Kamata Y; Sakaguchi G
    Infect Immun; 1987 Dec; 55(12):3051-6. PubMed ID: 2824382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.
    Kozaki S; Onimaru J; Kamata Y; Sakaguchi G
    Infect Immun; 1991 Jan; 59(1):457-9. PubMed ID: 1987060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.